Aetna: Data Collection Requirement for Prescription Drug Data Collection Reporting Submission

Aetna began sending the following information to groups via email on Friday, March 15th, requesting information for them to complete for the RxDC reporting requirements. Groups must respond by April 12, 2024.

Prescription Drug Data Collection (RxDC) reporting for reference year 2023 is required to be submitted no later than June 1, 2024. This submission must include certain data elements that were not required for the initial submission. 

As always, Aetna is committed to complying with all legal and regulatory requirements affecting their business operations and their customer's health benefits. Therefore, Aetna has developed a process to support plan sponsors in the submission of these reports.

In 2024, Aetna will require the following data from all plan sponsors included in Aetna’s D1 file:

• Total premium paid by members for the reference year
• Total premium paid by employer for the reference year
• Funding Arrangement
• Issuer Name/Legal Entity

If a self-insured plan sponsor requests to be excluded from Aetna’s D1 file, you do not need to complete this data collection process. Instead, plan sponsors should contact their account representative to request an exception.

To learn more about the reporting requirements, refer to the RxDC Reporting Instructions.

What plan sponsors need to do:

Complete the fields provided in the emailed form no later than April 12, 2024.

• If any plan sponsor does not provide the requested data by April 12th, Aetna will submit the report without the required plan sponsor data. Failure to respond with complete and correct information will impact Aetna's ability to accurately report on the plan sponsor’s behalf, and Aetna will not be responsible for any liability associated with the inaccurate report. It may be necessary for you to submit this information to CMS directly.

If you have any questions or want to discuss this process, please contact your Aetna sales team.